<DOC>
	<DOCNO>NCT01960569</DOCNO>
	<brief_summary>Single centre , Phase IV , interventional , The study include : 200 patient , 100 Patients Topical r-Hirudin ( Thrombexx ) 100 patient placebo . The patient randomize active product ( arm 1 ) placebo ( arm 2 ) . The study consist 4 visit follow : - Visit 1 : day 1 check patient eligibility also randomization . - Visit 2 : day 4 ass target parameter - Visit 3 : day 8 ass target parameter - Visit 4 : day 16 ass target parameter</brief_summary>
	<brief_title>Topical r-Hirudin ( Thrombexx ) Efficacy Treatment Haematomas</brief_title>
	<detailed_description>Single centre , Phase IV , interventional , The study include : * 200 patient , 100 Patients Topical r-Hirudin ( Thrombexx ) 100 patient placebo . The patient randomize active product ( arm 1 ) placebo ( arm 2 ) . The study consist 4 visit follow : - Visit 1 : day 1 check patient eligibility also randomization . - Visit 2 : day 4 ass target parameter - Visit 3 : day 8 ass target parameter - Visit 4 : day 16 ass target parameter - Study objective : Assessment Efficacy Topical r-Hirudin treatment haematoma , also resolve associate oedema - Study duration : 6 month - Selection trial subject : Inclusion Criteria : 1 . Age patient 20 60 year old . 2 . Patients type haematoma . Exclusion Criteria : 1 . Presence infect wound require hospitalization surgical intervention . 2 . History allergy hypersensitivity ingredient . 3 . Patients coagulation disorder like haemophilia . 4 . Patients anticoagulant like Warfarin Acetylsalicylic acid . 5 . Patients take digestive enzyme like alfa chemotrypsin . - Target parameter : 1.Size haematoma . ( Measured ruler ) , The ruler measure long 2 intersect line . 2.Size oedema : measurement oedema circumference 3.Pain ( Vas score ) . 4.Change colour ( colour grade scale ) .</detailed_description>
	<mesh_term>Hematoma</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Age patient 20 60 year old . Patients types haematoma . Presence infect wound require hospitalization surgical intervention . History allergy hypersensitivity ingredient . Patients coagulation disorder like haemophilia . Patients anticoagulant like Warfarin Acetylsalicylic acid . Patients take digestive enzyme like alfa chemotrypsin .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Thrombexx</keyword>
	<keyword>Topical r-Hirudin</keyword>
	<keyword>Efficacy</keyword>
	<keyword>haematoma</keyword>
</DOC>